Simon Harnest, MSc
Simon Harnest is responsible for the capital markets and portfolio strategy at Metagenomi. With over 10 years of leadership experience in the biotech sector, Simon has raised over $1 billion in equity proceeds, most recently as CIO of Cellectis, where he was instrumental in orchestrating the NASDAQ listings for both Cellectis and its subsidiary Calyxt.
CIO & SVP of Investor Relations
Prior to Cellectis, Simon was Vice President at Trout Group (now Solebury Trout) and a Registered Representative with Trout Capital, a leading investor relations firm and broker-dealer focused on the life sciences industry.
Simon holds a Master of Science in Public Health from the London School of Economics and Political Science and a Bachelor of Science in Economics from the Westminster Business School, University of Westminster.